QA: Larimar Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001374690_2020_Larimar_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001374690, Larimar Therapeutics Inc

  xvar xval
0 AssetsCurrent 71,503,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 821,000
3 remainder_Assets 8,410,000
4 LiabilitiesCurrent 12,190,000
5 LiabilitiesNoncurrent 6,456,000
6 remainder_Liabilities 8,464,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,107,499
9 ResearchAndDevelopmentExpense 29,466,942
10 remainder_Expenses 5,553,000
11 remainder_Revenues 0
12 remainder_NetIncome 92,658
13 remainder_ComprehensiveNetIncome 49,460
  yvar yval
0 Assets 80,734,000
1 Liabilities 27,110,000
2 Expenses 51,127,441
3 Revenues 0
4 StockholdersEquity 53,624,000
5 NetIncome -51,034,783
6 ComprehensiveNetIncome -51,010,053
7 BaseVar 79,556,780
8 EconomicCapitalRatiobeforeLimitedLiability 1.22
9 EconomicCapitalRatio 2.47

Edgar->Model Mapping

Feature Distribution

Change over Time